Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1996
11/12/1996US5574138 Epithelium-derived T-cell factor
11/12/1996US5574132 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
11/12/1996US5573943 Cloning and expression of a rhoptry associated protein of P. falciparum
11/12/1996US5573924 Novel receptor cytokine, protein
11/12/1996US5573920 Antibodies, and methods for their use
11/12/1996US5573918 Process and reagent for specific determination of pancreatic alpha amylase
11/12/1996US5573767 Lutenizing hormone-releasing hormone
11/12/1996US5573762 Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
11/12/1996CA2017507C Adjuvant formulation comprising a submicron oil droplet emulsion
11/12/1996CA1338708C Neisserial vaccines
11/12/1996CA1338706C Monoclonal anti-human breast cancer antibodies suitable for imaging breast cancer
11/12/1996CA1338705C Vaccines obtained from antigenic gene products of recombinant genes
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034960A1 High molecular weight major outer membrane protein of moraxella
11/07/1996WO1996034958A1 Vasoactive intestinal peptide
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
11/07/1996WO1996034942A1 Novel retrovirus and diagnostic methods
11/07/1996WO1996034893A1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
11/07/1996WO1996034892A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
11/07/1996WO1996034888A1 Modulation of cholesteryl ester transfer protein (cetp) activity
11/07/1996WO1996034886A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
11/07/1996WO1996034884A2 Synthetic peptides of m. gallisepticum, antibodies thereto, their preparation and use
11/07/1996WO1996034883A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034631A1 Method for introducing and expressing genes in animal cells
11/07/1996WO1996034626A1 Composition of tyrosine and polymerised allergen
11/07/1996WO1996034625A1 Recombinant vesiculoviruses and their uses
11/07/1996WO1996034624A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
11/07/1996WO1996034623A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034622A1 Modified myelin protein molecules
11/07/1996WO1996034616A1 Serum preparations for inhibiting retroviruses and tumor growth
11/07/1996WO1996030520A3 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
11/07/1996WO1996029409A3 Rage tumor rejection antigens
11/07/1996WO1996015241A3 A polynucleotide tuberculosis vaccine
11/07/1996DE19510344C1 Verwendung einer Tumorvakzine Use of a tumor vaccine
11/07/1996CA2433502A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996CA2231854A1 Novel retrovirus and diagnostic methods
11/07/1996CA2219994A1 Method for introducing and expressing genes in animal cells
11/07/1996CA2219936A1 Vasoactive intestinal peptide
11/07/1996CA2219899A1 Shark serum preparations for inhibiting retroviruses and tumor growth
11/07/1996CA2219889A1 High molecular weight major outer membrane protein of moraxella
11/07/1996CA2218858A1 Modified myelin protein molecules
11/07/1996CA2217388A1 Composition of tyrosine and polymerised allergen
11/06/1996EP0740939A1 Compositions for treatment and prophylaxis of atherosclerosis
11/06/1996EP0740792A1 Peptomers with enhanced immunogenicity
11/06/1996EP0740707A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740703A1 Diagnosis and treatment of infections due to streptococci and enterococci
11/06/1996EP0740553A1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
11/06/1996EP0485591B1 Method for isolating deletion mutants of vibrio cholerae and cultures containing vibrio cholerae
11/06/1996EP0413763B1 Method for the production of monoclonal antibodies utilizing a germfree animal
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
11/06/1996CN1135182A Immunoloigcal tolerance-inducting agent
11/06/1996CN1135181A Alteration of immune response using pan Dr-binding peptides
11/06/1996CN1033215C Process for prepn. of biologic medicine for anti tumour
11/05/1996US5571895 Modified GAF polypeptides
11/05/1996US5571718 Cloning and expression of soluble truncated variants of Borrelia OspA, OspB and Vmp7
11/05/1996US5571712 Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats
11/05/1996US5571702 Amplification method for detection of human PF4A receptors
11/05/1996US5571694 Expression of tetanus toxin fragment C in yeast
11/05/1996US5571531 Microparticle delivery system with a functionalized silicone bonded to the matrix
11/05/1996US5571515 Compositions and methods for use of IL-12 as an adjuvant
11/05/1996US5571512 Pharmaceutical composition against AIDS
11/05/1996US5571511 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/05/1996US5571500 Treatment of autoimmune diseases through administration by inhalation of autoantigens
11/05/1996US5571499 Treatment of diseases with autoimmune fragments and collagen
10/1996
10/31/1996WO1996034106A1 Decorin binding protein compositions and methods of use
10/31/1996WO1996034105A1 Modified polypeptides for enhanced immunogenicity
10/31/1996WO1996034103A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/31/1996WO1996034100A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996WO1996034015A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
10/31/1996WO1996034005A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
10/31/1996WO1996033746A1 Treatment of tumors with cells expressing interferons, tumor necrosis factors, or other cytokines
10/31/1996WO1996033740A1 Use of leukemia inhibitory factor and endothelin antagonists
10/31/1996WO1996033739A1 Vaccines containing a saponin and a sterol
10/31/1996WO1996033738A1 Improved virus vaccines
10/31/1996WO1996033737A1 Peptide-based vaccine against papillomavirus infection
10/31/1996WO1996033736A1 Malaria peptides and vaccines
10/31/1996WO1996033735A1 Human antibodies derived from immunized xenomice
10/31/1996WO1996033734A1 A pluripotent vaccine against enveloped viruses
10/31/1996WO1996033732A1 Multimeric, recombinant urease vaccine
10/31/1996WO1996033726A1 Preparation and use of sulfated oligosaccharides
10/31/1996DE19516673A1 Vaccines against human, pref. mucin expressing, tumours
10/31/1996CA2761116A1 Human antibodies derived from immunized xenomice
10/31/1996CA2222283A1 Improved virus vaccines
10/31/1996CA2219996A1 Immortalised cell lines from human adipose tissue, process for preparing same and applications thereof
10/31/1996CA2219339A1 A pluripotent vaccine against enveloped viruses
10/31/1996CA2219201A1 Multimeric, recombinant urease vaccine
10/31/1996CA2218987A1 Modified polypeptides for enhanced immunogenicity
10/31/1996CA2218492A1 Decorin binding protein compositions and methods of use
10/30/1996EP0739981A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/30/1996EP0739414A1 Herpesvirus replication defective mutants
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739214A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
10/30/1996EP0739211A1 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope
10/30/1996EP0512071B1 Method and compositions for inhibiting angiogenesis
10/30/1996CN1134704A Drug binding protein
10/30/1996CN1134461A Rabbit hemorrhagic disease virus (RHDV) recombinant capsids and proteins, diagnostic kits and vaccines containing said RHDV recombinant capsids and proteins
10/30/1996CN1134458A Donkey leukocyte hypotoxic strain for equine infection anemia and its culture method
10/29/1996US5569825 Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
1 ... 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 ... 1823